S861 The Differences in the Clinicopathological Features of Early-Stage Adenocarcinomas of the Esophagogastric Junction Between the United States and Japan

Introduction: The incidence of adenocarcinomas of the esophagogastric junction (EGJ) has been increasing in both the United States and Japan. To better understand the pathogenesis of EGJ adenocarcinomas in these 2 populations, we compared early-stage tumors between American and Japanese patients. Methods: Internal review board-approved analysis of clinicopathological features of 42 American patients (AP) (43 lesions) and 93 Japanese patients (JP) (93 lesions) with Siewert type 1 or 2 and Vienna pathologic diagnosis 4 or 5 treated by endoscopic resection. Statistical differences between both cohorts were defined as P < 0.05. Results: No significant differences were found in median age in years (68 years [34-86] vs 72 years [39-85]) and male-to-female ratio (34:8 vs 80:13) for AP and JP. Tumor location (confined within the esophagus/involving the EGJ/confined within the stomach) was found in 21/21/1 in AP vs 20/36/37 in JP, with gastric location more frequent in JP (P < 0.01). After excluding tumors confined within the stomach, there were no significant differences in the mean tumor size (19.6 ± 9.32 mm vs 20 mm ± 10.1 mm) and depth of invasion (mucosa/submucosa: 27/15 vs 43/13) between AP and JP. The distribution of elevated/flat/depressed types was found in 35/7/0 in AP vs 31/6/19 in JP (P < 0.01), with depressed lesions occurring exclusively in JP. Well or high-grade dysplasia/moderately/poorly differentiated/other tumor types were found in 24/14/4/0 in AP vs 48/4/1/3 in JP (P < 0.01). Among tumors with submucosal invasion, histologic types in submucosal areas showed a trend toward significance (1/9/3/0 in AP vs 6/5/1/0 in JP) (P = 0.05). The length of columnar-lined esophagus also differed: long/short/none 18/16/7 in AP vs 12/37/7 in JP (P = 0.03). While long-segment was more common in AP, JP showed higher Prague C&M values (1.5 ± 2.0/4.7 ± 1.7 in AP vs 4.7 ± 5.0/8.0 ± 5.3 in JP) (P = 0.02). Intestinal metaplasia showed a trend toward higher prevalence in AP: 30/12 positive/negative in AP vs 29/27 in JP (P = 0.06). Tumor extension under squamous epithelium was more common in AP (35/6 positive/negative in AP vs 19/30 in JP) (P < 0.01). Positive horizontal margins occurred exclusively in AP (33/9/0 positive/negative/unknown in AP vs 0/54/2 in JP) (P < 0.01). Conclusion: This analysis revealed significant differences in macroscopic types, tumor grade and background mucosa between AP and JP with early-stage EGJ adenocarcinomas. These findings suggest distinct pathways of carcinogenesis.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001130904.72944.ff
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S861 The Differences in the Clinicopathological Features of Early-Stage Adenocarcinomas of the Esophagogastric Junction Between the United States and Japan

Gregory Y. Lauwers, Keiko Yamamoto, Emi Takakuwa, Naoya Sakamoto et al.
The American Journal of Gastroenterology
Esophageal Cancer Research and Treatment
article

S861 The Differences in the Clinicopathological Features of Early-Stage Adenocarcinomas of the Esophagogastric Junction Between the United States and Japan

Gregory Y. Lauwers, Keiko Yamamoto, Emi Takakuwa, Naoya Sakamoto, Hiroaki Takahashi, José M. Pimiento, Schaffer Mok, Yukihiro Nakanishi
article en

Abstract

Introduction: The incidence of adenocarcinomas of the esophagogastric junction (EGJ) has been increasing in both the United States and Japan. To better understand the pathogenesis of EGJ adenocarcinomas in these 2 populations, we compared early-stage tumors between American and Japanese patients. Methods: Internal review board-approved analysis of clinicopathological features of 42 American patients (AP) (43 lesions) and 93 Japanese patients (JP) (93 lesions) with Siewert type 1 or 2 and Vienna pathologic diagnosis 4 or 5 treated by endoscopic resection. Statistical differences between both cohorts were defined as P < 0.05. Results: No significant differences were found in median age in years (68 years [34-86] vs 72 years [39-85]) and male-to-female ratio (34:8 vs 80:13) for AP and JP. Tumor location (confined within the esophagus/involving the EGJ/confined within the stomach) was found in 21/21/1 in AP vs 20/36/37 in JP, with gastric location more frequent in JP (P < 0.01). After excluding tumors confined within the stomach, there were no significant differences in the mean tumor size (19.6 ± 9.32 mm vs 20 mm ± 10.1 mm) and depth of invasion (mucosa/submucosa: 27/15 vs 43/13) between AP and JP. The distribution of elevated/flat/depressed types was found in 35/7/0 in AP vs 31/6/19 in JP (P < 0.01), with depressed lesions occurring exclusively in JP. Well or high-grade dysplasia/moderately/poorly differentiated/other tumor types were found in 24/14/4/0 in AP vs 48/4/1/3 in JP (P < 0.01). Among tumors with submucosal invasion, histologic types in submucosal areas showed a trend toward significance (1/9/3/0 in AP vs 6/5/1/0 in JP) (P = 0.05). The length of columnar-lined esophagus also differed: long/short/none 18/16/7 in AP vs 12/37/7 in JP (P = 0.03). While long-segment was more common in AP, JP showed higher Prague C&M values (1.5 ± 2.0/4.7 ± 1.7 in AP vs 4.7 ± 5.0/8.0 ± 5.3 in JP) (P = 0.02). Intestinal metaplasia showed a trend toward higher prevalence in AP: 30/12 positive/negative in AP vs 29/27 in JP (P = 0.06). Tumor extension under squamous epithelium was more common in AP (35/6 positive/negative in AP vs 19/30 in JP) (P < 0.01). Positive horizontal margins occurred exclusively in AP (33/9/0 positive/negative/unknown in AP vs 0/54/2 in JP) (P < 0.01). Conclusion: This analysis revealed significant differences in macroscopic types, tumor grade and background mucosa between AP and JP with early-stage EGJ adenocarcinomas. These findings suggest distinct pathways of carcinogenesis.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 48%
Esophageal Cancer Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.